STSS Average Annual Return Since 2022
Growth of $10,000.00
Without Dividends Reinvested Into STSS


Also see:
STSS stock yearly return 2023
STSS YTD return
Compare STSS average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 04/18/2022
End date: 04/25/2024
Start price/share: $1.73
End price/share: $0.28
Dividends collected/share: $0.00
Total return: -83.53%
STSS Average Annual Return: -59.01%
Starting investment: $10,000.00
Ending investment: $1,647.66
Years: 2.02


STSS average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Sharps Technology is a medical device company that has designed and patented various safety syringes. Co.'s safety syringes, Sharps Provensa has passive safety features. Co.'s suite of products is designed to work with vials as well as pre-fillable syringes which are largely used by the pharmaceutical industry. The Sharps Provensa needle tip goes through the skin sharp, delivering the medicine or vaccine, and comes out of the body shielded, protecting the healthcare worker and the public. The Sharps Provensa will be usable in all various settings, including hospitals, clinics, physician offices, and pharmacies. The STSS average annual return since 2022 is shown above.

The Average Annual Return on the STSS average annual return since 2022 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether STSS average annual return since 2022 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the STSS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree STSS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sharps Technology (STSS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

STTK Average Annual Return
SUPN Average Annual Return
SVRA Average Annual Return
SWAV Average Annual Return
SWTX Average Annual Return
SXTP Average Annual Return
SYBX Average Annual Return
SYK Average Annual Return
SYRE Average Annual Return
SYRS Average Annual Return
More Healthcare companies »

 

STSS Average Annual Return Since 2022 | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.